Pharmaceuticals and Healthcare Reports
Japan Dyslipidemia Market

Veröffentlicht am 26 April 2017 in "Gesundheit & Fitness, Gesundheit & Fitness", Sprache — English. 3 Seiten.

Beschreibung der Publikation:

The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors will reshape the sales landscape of the dyslipidemia market moving forward. Mehr anzeigen

Tags anzeigen

Tags: japan dyslipidemia market analysis

Lesen Download

KOSTENLOSES Abonnement

Andere Publikationen von "Pharmaceuticals and Healthcare Reports"

Alle Publikationen anzeigen

Pharmaceuticals and Healthcare Reports Japan Dyslipidemia Market

Andere Publikationen von "Pharmaceuticals and Healthcare Reports"

Ähnliche Magazine

Pharmaceuticals and Healthcare Reports
Japan Dyslipidemia Market